Cargando…
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
Flaws in the design, conduct, analysis, and reporting of randomised trials can cause the effect of an intervention to be underestimated or overestimated. The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate
Autores principales: | Higgins, Julian P T, Altman, Douglas G, Gøtzsche, Peter C, Jüni, Peter, Moher, David, Oxman, Andrew D, Savović, Jelena, Schulz, Kenneth F, Weeks, Laura, Sterne, Jonathan A C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196245/ https://www.ncbi.nlm.nih.gov/pubmed/22008217 http://dx.doi.org/10.1136/bmj.d5928 |
Ejemplares similares
-
Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation
por: Savović, Jelena, et al.
Publicado: (2014) -
Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews
por: Jørgensen, Lars, et al.
Publicado: (2016) -
A new large-scale meta-epidemiological study on bias in randomized trials using routinely collected risk-of-bias assessments by cochrane reviewers: results from the robes study
por: Savovic, Jelena, et al.
Publicado: (2015) -
The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration
por: Turner, Lucy, et al.
Publicado: (2013) -
The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder
por: Boesen, Kim, et al.
Publicado: (2017)